Search Results 1411-1420 of 16817 for monoclonal antibody

1. Resources - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

   Epidemiology of Monoclonal B-Cell Lymphocytosis Study · Resources · Contact. Resources. Explore resources related to Dr. Slager's B-Cell Lymphoproliferative ...

2. Clinical trials - Oncology (Medical)

   The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...

3. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Subject has received prior investigational therapy directed at BCMA including, but not limited to, bispecific T cell-engaging antibodies or molecules, antibody ...

4. Alternative cancer treatments: 11 options to consider - Mayo Clinic

   High-dose vitamin C: Can it kill cancer cells? Low blood counts · Measles Virus as a Cancer Fighter · Monoclonal antibody drugs · Mort Crim and Cancer · Mouth ...

5. A Study Evaluating the Addition of Venetoclax (ABT-199) to Patients with Multiple Myeloma who are Receiving Bortezomib and Dexamethasone as Standard Therapy - Mayo Clinic

   Amyloidosis; POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes); Known Human Immunodeficiency Viral (HIV) ...

6. Microscopic Polyangiitis Clinical Trials - Mayo Clinic Research

   ... antibody (ANCA)-associated vasculitis (AAV). PR3-AAV Resilient Remission or PRRR Rochester, MN. The purpose of this study is to determine the proportion of ...

7. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

   Must have received a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 antibody; ... monoclonal protein, and skin changes), or clinically ...

8. Chemotherapy and hair loss: What to expect during treatment - Mayo Clinic

   Monoclonal antibody drugs · Mort Crim and Cancer · Mouth cancer · What is mouth cancer? A Mayo Clinic expert explains · Mouth cancer FAQs · Mouth sores caused ...

9. SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Serum monoclonal protein ≥ 1.0 g/dL; ≥ 200 mg of monoclonal protein in the ... Monoclonal plasmacytosis ≥ 30% (evaluable disease); Measurable ...

10. Jyoti Kumari Lama: Addressing Life-Threatening Allergic Reactions - Student Research - Mayo Clinic College of Medicine & Science

    For one, my study found that a specialized subset of immune cells, known as T follicular helper cells or Tfh cells, and IgG antibodies play an important ...